Skip to main content
. 2022 Apr 27;11(2):e001699. doi: 10.1136/bmjoq-2021-001699

Table 2.

Characteristics related to perceptions of MDRO screening

Screening is responsibility of ED Screening is a high priority
N (%) P value1 N (%) P value1
Knowledge of MDRO prevalence 0.001 0.846
<20% 5 (71.4) 2 (28.6)
20%–39% 24 (85.7) 8 (26.7)
40%–59% 16 (76.2) 6 (27.3)
≥60% 14 (93.3) 6 (42.9)
Don’t know 16 (45.7) 10 (27.8)
Knowledge of MDROs to be screened systematically in the hospital 0.999 0.507
Do not know all MDROs to be screened systematically 71 (70.3) 33 (31.7)
Know all MDROs to be screened systematically 7 (70.0) 2 (20.0)
Knowledge of IPC measures to avoid cross-transmission 0.199 0.171
0 correct answers 3 (75.0) 2 (66.7)
1–2 correct answers 59 (74.7) 26 (32.9)
3 correct answers 16 (57.1) 7 (21.9)
No of years in your current profession 0.104 0.024
0–2 3 (100.0) 1 (25.0)
3–5 8 (53.3) 1 (6.3)
6–10 years 14 (58.3) 4 (17.4)
≥11 years 52 (76.5) 28 (40.0)
No of years in the hospital 0.421 0.108
<1 0 (0.0) 0 (0)
1–2 7 (63.6) 1 (8.3)
3–5 14 (66.7) 5 (21.7)
6–10 57 (73.1) 29 (37.2)
Specialised training in emergency care 0.055 0.291
Yes 33 (60.0) 18 (31.0)
No 27 (81.8) 12 (35.3)
Ongoing 12 (70.6) 2 (12.5)
Not applicable 6 (100.0) 3 (50.0)
Course in infection prevention 0.462 0.145
No 21 (77.8) 11 (39.3)
Yes 52 (68.4) 19 (24.1)
Participation in working group, committee in risk management 0.257
Yes, I am currently participating 10 (83.3) 6 (50.0)
Yes, in the past, but I am not currently participating 11 (84.6) 6 (46.2)
No 57 (66.3) 23 (25.8)

Data are n (%).

χ2 test.

ED, emergency department; IPC, infection prevention and control; MDRO, multidrug-resistant organism.